These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3046293)

  • 41. [Value of training-induced effects on arterial vascular system and skeletal muscles in therapy of NYHA II/III heart failure].
    Huonker M; Keul J
    Z Kardiol; 2001 Nov; 90(11):813-23. PubMed ID: 11771449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure.
    Galatius S; Wroblewski H; Sørensen V; Haunsø S; Nørgaard T; Kastrup J
    J Card Fail; 1999 Mar; 5(1):17-24. PubMed ID: 10194656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure.
    Rajagopalan B; Conway MA; Massie B; Radda GK
    Am J Cardiol; 1988 Sep; 62(8):53E-57E. PubMed ID: 3414538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].
    Drexler H; Truog AG; Just H; Zelis R
    Klin Wochenschr; 1985 Mar; 63(6):262-7. PubMed ID: 3887015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Abnormalities of the peripheral circulation and tolerance to exertion of patients with heart failure].
    Cohen-Solal A; Aupetit JF; Guéret P; Kayanakis J; Zannad F
    Arch Mal Coeur Vaiss; 1989 Apr; 82(4):593-8. PubMed ID: 2500914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Congestive heart failure: from cardiac muscle to skeletal muscle].
    Ferrari R; Bernocchi P; Boraso A; Visioli O
    Cardiologia; 1993 Dec; 38(12 Suppl 1):45-50. PubMed ID: 8020046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
    Shah KR; Ganguly PK; Netticadan T; Arneja AS; Dhalla NS
    Can J Physiol Pharmacol; 2004 Jul; 82(7):438-47. PubMed ID: 15389290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assessment of daily physical activity levels in patients with chronic heart failure by measuring energy expenditure--effects of converting enzyme inhibitor therapy.
    Sato H; Hori M; Ozaki H; Yokoyama H; Imai K; Katsube Y; Morikawa M; Inoue M; Kamada T
    Jpn Circ J; 1995 Oct; 59(10):647-53. PubMed ID: 8558748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of congestive heart failure. Role of angiotensin-converting enzyme inhibitors.
    Sonnenblick EH; LeJemtel TH
    Am J Med; 1989 Dec; 87(6B):88S-91S. PubMed ID: 2532468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. The Australian Zestril (Lisinopril) Study Group.
    Sloman G
    Am J Cardiol; 1992 Oct; 70(10):113C-118C. PubMed ID: 1329466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.
    Massie BM; Conway M; Rajagopalan B; Yonge R; Frostick S; Ledingham J; Sleight P; Radda G
    Circulation; 1988 Aug; 78(2):320-6. PubMed ID: 3396168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
    Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
    Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiocirculatory dynamics in the normal and failing heart.
    Zelis R; Flaim SF; Liedtke AJ; Nellis SH
    Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
    Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF
    J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.